These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23531874)
1. A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal. Janku F; Huang HJ; Angelo LS; Kurzrock R Oncotarget; 2013 Mar; 4(3):463-73. PubMed ID: 23531874 [TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines. Zhao H; Desai V; Wang J; Epstein DM; Miglarese M; Buck E Mol Cancer Ther; 2012 Feb; 11(2):503-13. PubMed ID: 22161861 [TBL] [Abstract][Full Text] [Related]
3. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128 [TBL] [Abstract][Full Text] [Related]
4. ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer. Zinn RL; Gardner EE; Marchionni L; Murphy SC; Dobromilskaya I; Hann CL; Rudin CM Mol Cancer Ther; 2013 Jun; 12(6):1131-9. PubMed ID: 23515613 [TBL] [Abstract][Full Text] [Related]
5. Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma. Kuhn DJ; Berkova Z; Jones RJ; Woessner R; Bjorklund CC; Ma W; Davis RE; Lin P; Wang H; Madden TL; Wei C; Baladandayuthapani V; Wang M; Thomas SK; Shah JJ; Weber DM; Orlowski RZ Blood; 2012 Oct; 120(16):3260-70. PubMed ID: 22932796 [TBL] [Abstract][Full Text] [Related]
6. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis. Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506 [TBL] [Abstract][Full Text] [Related]
7. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593 [TBL] [Abstract][Full Text] [Related]
8. In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. Leiphrakpam PD; Agarwal E; Mathiesen M; Haferbier KL; Brattain MG; Chowdhury S Oncol Rep; 2014 Jan; 31(1):87-94. PubMed ID: 24173770 [TBL] [Abstract][Full Text] [Related]
9. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells. Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro. Shu S; Yang Y; Li X; Li T; Zhang Y; Xu C; Liang C; Wang X Mol Cell Biochem; 2011 Jul; 353(1-2):225-33. PubMed ID: 21442237 [TBL] [Abstract][Full Text] [Related]
12. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways. Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537 [TBL] [Abstract][Full Text] [Related]
13. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro. Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144 [TBL] [Abstract][Full Text] [Related]
14. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894 [TBL] [Abstract][Full Text] [Related]
15. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. Ucar DA; Kurenova E; Garrett TJ; Cance WG; Nyberg C; Cox A; Massoll N; Ostrov DA; Lawrence N; Sebti SM; Zajac-Kaye M; Hochwald SN Cell Cycle; 2012 Sep; 11(17):3250-9. PubMed ID: 22894899 [TBL] [Abstract][Full Text] [Related]
16. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells. Li P; Veldwijk MR; Zhang Q; Li ZB; Xu WC; Fu S BMC Cancer; 2013 Jun; 13():297. PubMed ID: 23777562 [TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression. Cornu M; Modi H; Kawamori D; Kulkarni RN; Joffraud M; Thorens B J Biol Chem; 2010 Apr; 285(14):10538-45. PubMed ID: 20145256 [TBL] [Abstract][Full Text] [Related]
18. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination. Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206 [TBL] [Abstract][Full Text] [Related]
19. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Min HY; Yun HJ; Lee JS; Lee HJ; Cho J; Jang HJ; Park SH; Liu D; Oh SH; Lee JJ; Wistuba II; Lee HY Mol Cancer; 2015 Jun; 14():113. PubMed ID: 26041671 [TBL] [Abstract][Full Text] [Related]
20. IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide. Ramcharan R; Aleksic T; Kamdoum WP; Gao S; Pfister SX; Tanner J; Bridges E; Asher R; Watson AJ; Margison GP; Woodcock M; Repapi E; Li JL; Middleton MR; Macaulay VM Oncotarget; 2015 Nov; 6(37):39877-90. PubMed ID: 26497996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]